Prolight receives first order of approximately SEK 19.9 million from BRAINBox
Prolight receives first order of approximately SEK 19.9 million from BRAINBox
Prolight Diagnostics AB (publ) today announces that the company has received its first purchase order from BRAINBox Solutions under the supply agreement announced in September 2026. The order value amounts to approximately SEK 19.9 million and covers commercial products ahead of BRAINBox’s planned US launch in traumatic brain injury (TBI).
The order covers commercial products for BRAINBox’s diagnostic and prognostic solution for TBI, which incorporates Prolight’s point-of-care platform Psyros®.
“This first order under our supply agreement is an important milestone for Prolight. It confirms BRAINBox’s commitment to the launch and marks our transition from development work to commercial readiness,” said Ulf Bladin, CEO of Prolight Diagnostics.
Both companies expect demand for instruments and cartridges to grow as commercialization progresses.